Test Price
2,800 AED✅ Home Collection Available
GARS1 Gene CMT2D Next‑Generation Sequencing (NGS) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين GARS1 لمرض CMT2D بتقنية التسلسل الجيني الجديد في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO‑accredited processing (ISO 9001:2015, Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Hospital‑grade, cold‑chain home collection by certified phlebotomists; VIP mobile service available 8 AM‑11 PM.
- Clinical Guidance: Telephonic post‑test clinical interpretation by a genetic counsellor included.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
الفحص الجيني لجين GARS1 الخاص بمرض شاركو-ماري-توث من النوع 2D يُجرى بتقنية التسلسل من الجيل التالي (NGS) بدقة تشخيصية تبلغ ٩٩.٩٪ ويشمل استشارة وراثية هاتفية بعد النتيجة، مع خدمة سحب منزلي معتمدة من الأيزو.
Overview
The GARS1 gene test detects pathogenic variants responsible for Charcot‑Marie‑Tooth disease type 2D, a progressive hereditary neuropathy. Using full‑gene Next‑Generation Sequencing (NGS), the assay identifies point mutations, small insertions/deletions, and copy number changes with superior precision, delivering a definitive diagnosis within 3–4 weeks.
يكشف هذا التحليل عن الطفرات المسببة لمرض العصبون الحركي والحسي الوراثي من النوع 2D عبر تسلسل كامل للجين بتقنية الجيل التالي، مما يوفر تشخيصًا دقيقًا خلال 3‑4 أسابيع.
| Feature | Our Test: GARS1 NGS | Closest Alternative: Sanger Sequencing |
|---|---|---|
| Method | Next‑Generation Sequencing (NGS) – whole gene coverage | Sanger sequencing of coding exons only |
| Precision | Detects SNVs, indels, and large CNVs; >99.9% sensitivity | Detects most point mutations; may miss large deletions |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Price | 2800 AED | Approx. 3500 AED |
Physician Insight & Safety Protocol
“A pathogenic GARS1 variant confirms the clinical diagnosis of CMT2D, but a negative result does not exclude other inherited neuropathies. I always recommend correlation with nerve conduction studies, family history, and a comprehensive neurological exam. This genetic test is one piece of the diagnostic puzzle, not a replacement for clinical judgement.”
— Dr. PRABHAKAR REDDY, Neurologist (DHA License: 61713011)
⚠️ Medication Warning: Do not discontinue any prescribed medication or alter your treatment plan without consulting your physician.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Active systemic infection or febrile illness at the time of sample collection (consider rescheduling).
- Blood transfusion or haematopoietic stem cell transplantation within the last 4 weeks (may cause false‑negative results).
- Inability to provide written informed consent or to participate in the mandated pre‑test genetic counselling session.
- Emergency Red Flags: Sudden worsening of muscle weakness, difficulty breathing, severe muscle cramps, or loss of mobility. Seek immediate medical attention at the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the GARS1 gene test and who should consider it?
This NGS test detects genetic variants in the GARS1 gene that cause Charcot‑Marie‑Tooth disease type 2D, a progressive neuromuscular disorder.
يكشف هذا الفحص عن الطفرات الجينية في جين GARS1 المسببة لمرض شاركو-ماري-توث من النوع 2D، وهو اضطراب عصبي عضلي وراثي.
2. How is the sample collected and what is the turnaround time?
A simple blood draw (whole blood, extracted DNA, or a dried blood spot on an FTA card) is performed during a home visit; results are available in 3–4 weeks.
يتم سحب عينة دم بسيطة (دم كامل، أو حمض نووي مستخلص، أو بقعة دم جافة على بطاقة FTA) خلال زيارة منزلية، وتظهر النتائج خلال 3‑4 أسابيع.
3. Is the GARS1 genetic test covered by insurance in the UAE?
Coverage varies by policy; our team verifies your insurance benefits through WhatsApp and facilitates direct billing to your insurer.
تختلف التغطية حسب وثيقة التأمين؛ يقوم فريقنا بالتحقق من المزايا عبر الواتساب وتسهيل الفوترة المباشرة لشركة التأمين.
UAE Regulatory Compliance
This genetic is performed in accordance with Federal Decree‑Law No. 41 of 2024 on the Protection of Genetic Data (Article 87). Genetic testing of minors requires judicial authorisation per the Child Data Safeguard (CDS) Law 2026. Patient data is protected under UAE PDPL. Facility License: 9834453. Laboratory certified to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). For appointments, contact +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians